Quinolone carboxylic acids are a class of totally synthetic antibacterial agents which encompass 4‐oxo‐3‐quinolinecarboxylic acids as well as the corresponding 1,8‐naphthyridines, cinnolines, and pyrido [2,3‐
d
]‐pyrimidines. These classes are illustrated by ciprofloxacin, nalidixic acid, cinoxacin, and piromidic acid, respectively. Established quinolone antibacterial agents are ciprofloxacin, ofloxacin, enoxacin, norfloxacin, and pefloxacin. Quinolones exert their antibacterial activity by interfering with the replication of bacterial DNA by inhibition of the enzyme DNA gyrase. The critical reaction is the negative supercoiling of bacterial DNA, a process involving the breaking and resealing of double‐stranded circular DNA. The general method by which most newer fluoro quinolones are prepared involves a ring closure reaction to form the quinolone nucleus. For the most part quinolones are well tolerated with few reports of adverse reactions, but because of a concern that they cause arthropathy in juvenile animals, quinolones are contraindicated for children and during pregnancy. A second problem is adverse side effects of the central nervous system (CNS) and adverse reactions with other drugs. Earlier quinolones have had little impact on the domestic antiinfective market as their utility was limited primarily to urinary tract infections. Newer quinolones, because of safety, seemingly low propensity toward bacterial resistance, and vastly improved therapeutic utility, enjoy a much greater market share.